NDC 12064-019 is a Injection, Suspension, Liposomal in the Drug For Further Processing category. It is labeled and distributed by Glaxosmithkline Manufacturing Spa.
| Product ID | 12064-019_d035f7b3-3d8f-423a-8ad6-ee68464a68cb |
| NDC | 12064-019 |
| Product Type | Drug For Further Processing |
| Proprietary Name | NDC 12064-019 |
| Dosage Form | Injection, Suspension, Liposomal |
| Marketing Start Date | 2015-01-01 |
| Marketing Category | / DRUG FOR FURTHER PROCESSING |
| Labeler Name | GlaxoSmithKline Manufacturing SpA |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| DOXORUBICIN HYDROCHLORIDE | 2 mg/mL |